Загрузка...
Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.
Magnetic resonance-based measures of disease activity and progression are now routinely used in definitive phase III treatment trials of multiple sclerosis as important secondary outcome measures because they provide quantitative and objective confirmation of the primary clinical outcome measures. M...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
1996
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1303626/ https://ncbi.nlm.nih.gov/pubmed/8764625 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|